Results 101 to 110 of about 6,714 (194)

Safety and effectiveness of the combination of 5‐azacitidine and ruxolitinib in VEXAS syndrome: A single‐centre experience

open access: yes
British Journal of Haematology, Volume 208, Issue 3, Page 1133-1137, March 2026.
Gregorio Maria Bergonzi   +13 more
wiley   +1 more source

VEXAS Syndrome and Substance Use Disorders: A Large‐Scale, Propensity‐Matched, Case‐Control Analysis Revealing Immune‐Mediated Comorbidities

open access: yes
International Journal of Dermatology, Volume 65, Issue 3, Page 584-586, March 2026.
Kritin K. Verma   +4 more
wiley   +1 more source

Case report: VEXAS syndrome: first documented cases in Latin America

open access: yesFrontiers in Hematology
IntroductionVEXAS syndrome (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) is a recently identified disorder associated with somatic mutations in the UBA1 gene.
Carolina Ottati   +14 more
doaj   +1 more source

A de novo evolved gene in the house mouse regulates female pregnancy cycles

open access: yes, 2019
The de novo emergence of new genes has been well documented through genomic analyses. However, a functional analysis, especially of very young protein-coding genes, is still largely lacking.
Bekpen, C.   +7 more
core   +1 more source

Case report: VEXAS syndrome and literature review

open access: yesFrontiers in Hematology
VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) is a novel disorder first described in 2020. Patients are diagnosed by identifying a somatic mutation of the ubiquitin-like modifier-activating enzyme 1 (UBA1) gene.
Can Jones   +7 more
doaj   +1 more source

Analysis of a temperature‐sensitive mutation in Uba1: Effects of the click reaction on subsequent immunolabeling of proteins involved in DNA replication

open access: yesFEBS Open Bio, 2015
In our previous study, a Met‐to‐Ile substitution at amino acid 256 in the catalytic domain of Uba1 was determined in temperature‐sensitive CHO‐K1 mutant tsTM3 cells, which exhibited chromosomal instability and cell‐cycle arrest in the S to G2 phases with
Kimihiko Sugaya   +2 more
doaj   +1 more source

Current status and prospects of diagnosis and treatment of VEXAS syndrome [PDF]

open access: yesZhenduanxue lilun yu shijian
VEXAS (Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a recently recognized autoinflammatory disease involving multiple systems, caused by somatic mutations in the ubiquitin-like modifier activating enzyme 1 (UBA1) gene.
QIAN Haozhou, CHANG Chunkang
doaj   +1 more source

Az UV-sugárzás által károsított DNS Rad6 ubiquitin-konjugáló enzim által irányított, mutációt okozó illetve hibamentes replikációja Saccharomyces cerevisiae-ben = The Rad6 ubiquitin-conjugating enzyme dependent error-free and error-prone translesion DNA synthesis of UV-damaged DNA in Saccharomyces cerevisiae [PDF]

open access: yes, 2007
A környezetünkben jelenlévő és a metabolikusan keletkező reaktív ágensek is folyamatosan károsítják a DNS-t. A kijavítatlan DNS hibáknál elakadt replikációs villa mentésében játszik szerepet a RAD6-RAD18-függő DNS károsodást toleráló mechanizmus, mely ...
Haracska, Lajos, Unk, Ildikó
core  

Research Progress in VEXAS Syndrome

open access: yes罕见病研究
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is an adult-onset, X-linked clonal autoinflammatory disease caused by somatic mutations in the UBA1 gene, characterized by systemic inflammation accompanied by hematologic clonal ...
JIN Xianghong   +4 more
doaj   +1 more source

VEXAS Syndrome and Alzheimer’s Disease—Are There Connections?

open access: yesBrain Sciences
VEXAS syndrome and Alzheimer’s disease (AD), though distinct in clinical manifestations, share overlapping pathophysiological mechanisms, including systemic inflammation, protein misfolding, and vascular dysfunction.
Aleksandra Sowa   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy